News

Published on 23 Dec 2024 on Insider Monkey · via Yahoo Finance

Gilead Sciences (GILD) Made Big Announcements in Q3

Article preview image

Polaris Capital Management, an investment management company, released its third quarter 2024 investor letter. A copy of the same can be downloaded here....

Read the rest of the article
NASDAQ.GILD price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Is Gilead Sciences, Inc. (GILD) the Best Dividend Stock of 2024?

We recently compiled a list of the Top 20 Dividend Stocks of 2024. In this article, we are going ...

Insider Monkey · via Yahoo Finance 31 Dec 2024
Buffett Is Still Buying, Plus Insiders Love These 2 Biotech Stocks

Berkshire Hathaway returned to load up on one particular tech stock. Meanwhile, other insiders...

247wallst.com 29 Dec 2024
Jim Cramer on Gilead Sciences, Inc. (GILD): ‘I Don’t Think The Business Is Worth...

We recently compiled a list of the Jim Cramer Talked About These 8 Stocks. In this article, we ar...

Insider Monkey · via Yahoo Finance 27 Dec 2024
Here's How You Can Earn $100 In Passive Income By Investing In Gilead Sciences...

Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical company, discovers, develops and...

Benzinga · via Yahoo Finance 25 Dec 2024
Local vaccine biotech secures $50M Merck investment - Silicon Valley Business...

A Fremont pharmaceutical company received an investment of approximately $50 million — about $3.5...

The Business Journals 24 Dec 2024
Gilead Sciences invests $20.1 million in Assembly Biosciences By Investing.com

Gilead Sciences invests $20.1 million in Assembly Biosciences

Investing.com 23 Dec 2024
Gilead Sciences (GILD) Made Big Announcements in Q3

Polaris Capital Management, an investment management company, released its third quarter 2024 inv...

Insider Monkey · via Yahoo Finance 23 Dec 2024
Gilead Stock Gains 15.4% in a Year: Should You Buy, Sell or Hold?

Free Report) has put up a steady performance in 2024 amid a volatile market. Gilead has a...

Zacks 20 Dec 2024
GILD's Trodelvy Gets Second Breakthrough Therapy Tag for Lung Cancer

This deal is expected to reduce Gilead’s 2024 GAAP and non-GAAP EPS by about 1 cent. Gilead...

Zacks · via Yahoo Finance 18 Dec 2024
Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data,...

It was a busy week in the biotech sector with lots of regulatory and pipeline updates. Among...

Zacks · via Yahoo Finance 18 Dec 2024

Copyright Statfolio @ 2025

Social Accounts